- Report
- January 2022
- 120 Pages
Global
From €2389EUR$2,500USD£2,033GBP
- Report
- November 2022
- 120 Pages
Global
From €2389EUR$2,500USD£2,033GBP
- Report
- August 2022
Global
From €755EUR$790USD£642GBP
- Report
- August 2022
United States
From €1854EUR$1,940USD£1,577GBP
- Report
- August 2022
Global
From €755EUR$790USD£642GBP
- Report
- August 2021
Europe
From €3268EUR$3,420USD£2,781GBP
- Report
- August 2021
Global
From €3813EUR$3,990USD£3,244GBP
- Report
- February 2021
Global
From €2829EUR$2,960USD£2,407GBP
- Clinical Trials
- June 2020
- 182 Pages
Global
From €2389EUR$2,500USD£2,033GBP
- Clinical Trials
- December 2019
- 52 Pages
Global
From €2389EUR$2,500USD£2,033GBP
- Drug Pipelines
- March 2021
Global
From €1911EUR$2,000USD£1,626GBP
- Drug Pipelines
- September 2020
- 162 Pages
Global
From €1911EUR$2,000USD£1,626GBP
- Drug Pipelines
- August 2020
- 73 Pages
Global
From €1911EUR$2,000USD£1,626GBP
- Drug Pipelines
- July 2020
- 97 Pages
Global
From €1911EUR$2,000USD£1,626GBP
- Drug Pipelines
- June 2020
- 98 Pages
Global
From €1911EUR$2,000USD£1,626GBP
- Report
- May 2023
- 80 Pages
Global
From €3500EUR$3,923USD£3,082GBP
- Report
- October 2022
- 94 Pages
Global
From €1911EUR$2,000USD£1,626GBP
- Report
- May 2022
- 166 Pages
Global
From €1911EUR$2,000USD£1,626GBP
- Report
- June 2022
- 68 Pages
Global
From €1911EUR$2,000USD£1,626GBP
- Report
- May 2022
- 74 Pages
Global
From €1911EUR$2,000USD£1,626GBP
The Neuropathy Drug market is a subset of the Central Nervous System Drugs market, which includes drugs used to treat diseases and disorders of the brain, spinal cord, and peripheral nervous system. Neuropathy drugs are used to treat a variety of conditions, including diabetic neuropathy, postherpetic neuralgia, and chemotherapy-induced peripheral neuropathy. These drugs are typically administered orally, intravenously, or topically, and may include anticonvulsants, antidepressants, and opioids.
The Neuropathy Drug market is highly competitive, with a variety of companies offering products to treat a range of conditions. Some of the major players in the market include Pfizer, GlaxoSmithKline, Novartis, Merck, and Johnson & Johnson. Other companies, such as Eli Lilly, Sanofi, and AstraZeneca, also offer products in this market. Show Less Read more